Advanced Biomed Inc.
For the period ended Jun 30, 2026. Filed Oct 13, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Oct 13, 2026
ADVB$2.11+2.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a) The following documents are filed as part of this Report:
(1) Consolidated Financial Statements
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| PAGE | |
| Report of Independent Registered Public Accounting Firm (PCAOB ID.: 1171) | F-2 |
|---|---|
| Consolidated Balance Sheets as of June 30, 2026 and 2025 | F-3 |
| Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended June 30, 2026 and 2025 | F-4 |
| Consolidated Statements of Changes in Stockholders’ Equity for the Years Ended June 30, 2026 and 2025 | F-5 |
| Consolidated Statements of Cash Flows for the Years Ended June 30, 2026 and 2025 | F-6 |
| Notes to Consolidated Financial Statements | F-7 – F-24 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.